^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    BCDx Monitoring Test

    Company:
    Early Is Good
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    It is a bladder cancer monitoring urine-based test to monitor for recurrence. It can be performed in any size urology lab with a simple plate reader, results available in less than an hour, and 100% negative predictive value. It is ultrasensitive (attomolar (10^-18) sensitivity).
    Cancer:
    Bladder Cancer
    Method:
    In situ hybridisation and flow cytometry